Table of Contents
What changed
Revenue, which for this listed investment vehicle is dominated by portfolio returns rather than trading income, halved from NZ$34.6m to NZ$17.3m. Profit before tax fell 50.2% to NZ$15.4m and NPAT fell 52.7% to NZ$14.9m. Dividend income within revenue actually rose to NZ$1.9m from NZ$1.2m, so the decline is driven by lower realised/unrealised gains on the investment portfolio rather than by underlying income.
Net operating cash flow swung from a NZ$3.4m inflow to a NZ$23.8m outflow. Cash on hand nonetheless edged up to NZ$2.4m, total liabilities halved to NZ$2.0m, and equity rose 33.4% to NZ$225.9m. The interim dividend was lifted 6.3% to 1.68c per share.
What matters
- PBT is the cleaner read. The effective tax rate moved from a 2.1% benefit to a 3.1% charge, exaggerating the NPAT decline by about 2.5 percentage points against PBT. Both still show returns roughly halved.
- ROE compression. Return on equity fell from 18.7% to 6.6%, reflecting both a smaller profit and a materially larger equity base after capital raising activity implied by the NZ$56.5m equity uplift against only NZ$14.9m of retained earnings plus dividends paid.
- Dividend policy vs. earnings. The per-share distribution rose despite halved earnings, pushing the payout ratio versus NPAT from 10.5% to 25.8%. For an LIC this is a policy choice rather than an earnings signal, but the cover has thinned.
Expectations
No quantitative targets or forward guidance were disclosed in the excerpts. The only shape context available is FY21, when HY21 contributed roughly 60% of full-year revenue and NPAT — so HY21 was itself front-loaded. A simple annualisation of HY22 implies FY22 revenue near NZ$34.6m, well below the NZ$57.2m FY21 anchor, but for an investment vehicle this is simply a restatement of portfolio returns to date and says little about the second half, which will be determined by mark-to-market movements that cannot be forecast from this release.
Quality of result
For a listed investment company, reported earnings are inherently mark-to-market and low-durability: the NZ$15.4m PBT is a point-in-time valuation outcome, not a run-rate. The operating cash outflow of NZ$23.8m looks alarming against a NZ$3.4m prior inflow, and cash conversion has clearly deteriorated — but for a fund this line combines underlying income with net investment purchases and sales, so it is not a clean read on operating quality. The durable elements are the NZ$1.9m of dividend income (up on prior) and the stronger balance sheet, with equity at NZ$225.9m and liabilities down to NZ$2.0m. The headline profit itself should be treated as a portfolio valuation snapshot.
Unresolved
- What drove the NZ$56.5m equity increase — capital raisings, DRP uptake, or portfolio revaluation flowing through reserves — and how much of the cash outflow relates to net new investment deployment versus realised losses?
- Why are trade receivables, cash and dividend income moving in directions that are not obviously reconciled with a NZ$23.8m operating outflow? Without a capex line, a net investment purchases line, or a breakdown of the operating cash statement, the swing is not fully diagnosable from the excerpts.
- With the payout ratio rising to 25.8% of NPAT at a time of halved earnings, is the distribution being funded partly from realised gains or capital, and is that sustainable if portfolio returns remain soft?
This briefing cannot assess portfolio composition, underlying holdings performance, manager fees, NTA per share, or any implied discount/premium to NTA, none of which were disclosed in the provided data.
Key metrics
| Metric | HY22 | HY21 | Change |
|---|---|---|---|
| Revenue | $17.3m | $34.6m | -50.0% ↓ |
| Net profit after tax | $14.9m | $31.6m | -52.7% ↓ |
| Net cash inflow from operating activities | −$23.8m | $3.4m | -800.0% ↓ |
| Interim dividend per share | 1.7c | 1.6c | +6.3% ↑ |
| Operating profit | $15.4m | $31.0m | -50.2% ↓ |
| Profit before tax | $15.4m | $31.0m | -50.2% ↓ |
| Cash and cash equivalents | $2.4m | $2.1m | +15.9% ↑ |
| Total assets | $227.9m | $173.4m | +31.4% ↑ |
Reference: annolyse.ai/briefings/brm-hy22
Analytical metrics
| Metric | HY22 | HY21 | Context |
|---|---|---|---|
| PBT growth | -50.2% | — | cleaner earnings measure |
| Effective tax rate | 3.1% | -2.1% | — |
| Debtor days | 0.8 | 0.3 | +0.5 days |
| Trade debtors | $0.1m | $0.1m | +$0.0m |
| Payout ratio vs NPAT | 25.8% | — | — |
| ROE (annualised) | 6.6% | 18.7% | Weakening |
| HY21 share of FY21 revenue | 60.5% | — | Other half was 39.5% |
| HY21 share of FY21 NPAT | 60.4% | — | Other half was 39.6% |
| Profit from continuing operations | $14.9m | $31.6m | −$16.7m |
Reference: annolyse.ai/briefings/brm-hy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.